Assembly Biosciences, Inc., a clinical-stage biotechnology company, has appointed Luisa Stamm, MD, PhD, as chief medical officer. Dr. Stamm is an infectious disease specialist focused on the development of therapeutics for hepatitis C virus (HCV) and HIV. “We are excited to have Luisa joining the Assembly team. Her clinical training, research experience, and track record in drug development make her ideally suited to lead clinical activities across our HBV and microbiome programs,” said John ...